Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma

I. Ocrant,; L.F. Aparicio,

doi:10.1515/JPEM.1992.5.4.265

Home Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma

Article

Licensed

Unlicensed Requires Authentication

Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma

I. Ocrant, and L.F. Aparicio,

Published/Copyright: October 1, 1992

Published by

Become an author with De Gruyter Brill

Submit Manuscript Author Information Explore this Subject

From the journal Journal of Pediatric Endocrinology and Metabolism Volume 5 Issue 4

MLA
APA
Harvard
Chicago
Vancouver

MLA
APA
Harvard
Chicago
Vancouver

Ocrant,, I. and Aparicio,, L.F.. "Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma" Journal of Pediatric Endocrinology and Metabolism, vol. 5, no. 4, 1992, pp. 265-270. https://doi.org/10.1515/JPEM.1992.5.4.265

Ocrant,, I. & Aparicio,, L. (1992). Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma. Journal of Pediatric Endocrinology and Metabolism, 5(4), 265-270. https://doi.org/10.1515/JPEM.1992.5.4.265

Ocrant,, I. and Aparicio,, L. (1992) Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma. Journal of Pediatric Endocrinology and Metabolism, Vol. 5 (Issue 4), pp. 265-270. https://doi.org/10.1515/JPEM.1992.5.4.265

Ocrant,, I. and Aparicio,, L.F.. "Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma" Journal of Pediatric Endocrinology and Metabolism 5, no. 4 (1992): 265-270. https://doi.org/10.1515/JPEM.1992.5.4.265

Ocrant, I, Aparicio, L. Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma. Journal of Pediatric Endocrinology and Metabolism. 1992;5(4): 265-270. https://doi.org/10.1515/JPEM.1992.5.4.265

Copy

Copied to clipboard

BibTeX EndNote RIS

Published Online: 1992-10

You are currently not able to access this content.

Articles in the same Issue

TABLE OF CONTENTS
Infant of the Diabetic Mother
Use of Implanted Insulin Pumps to Treat IDDM
Urinary Growth Hormone: Its Relation to Growth and Development (The Wessex Growth Study)
Antiphospholipid Autoantibodies in Children with Insulin Dependent Diabetes Mellitus
Attitude Evaluation in Diabetic Children: The Role of Summer Camps
Serum Epidermal Growth Factor (EGF) and Platelet-Derived Growth Factor (PDGF) in Diabetic Patients Below Age 18
Elevated Creatine Kinase Activity: A Marker of Subtle Hypocortisolism in Hypopituitary Children
Delayed Involution of the Fetal Adrenal Cortex in Two Infants Simulating Non-Salt-Losing Congenital Adrenal Hyperplasia Due to a Deficiency of 3ß-Hydroxysteroid Dehydrogenase
Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma
Acromegaly without Pituitary Adenoma in McCune-Albright Syndrome, Successfully Treated with a Somatostatin Analog
BOOK REVIEWS

Search journal Search the content of this journal

https://doi.org/10.1515/JPEM.1992.5.4.265

Articles in the same Issue

TABLE OF CONTENTS
Infant of the Diabetic Mother
Use of Implanted Insulin Pumps to Treat IDDM
Urinary Growth Hormone: Its Relation to Growth and Development (The Wessex Growth Study)
Antiphospholipid Autoantibodies in Children with Insulin Dependent Diabetes Mellitus
Attitude Evaluation in Diabetic Children: The Role of Summer Camps
Serum Epidermal Growth Factor (EGF) and Platelet-Derived Growth Factor (PDGF) in Diabetic Patients Below Age 18
Elevated Creatine Kinase Activity: A Marker of Subtle Hypocortisolism in Hypopituitary Children
Delayed Involution of the Fetal Adrenal Cortex in Two Infants Simulating Non-Salt-Losing Congenital Adrenal Hyperplasia Due to a Deficiency of 3ß-Hydroxysteroid Dehydrogenase
Pediatric Use of Pergolide in Treating Prolactin-Secreting Pituitary Macroadenoma
Acromegaly without Pituitary Adenoma in McCune-Albright Syndrome, Successfully Treated with a Somatostatin Analog
BOOK REVIEWS